The Journal of Experimental Medicine
Avanti Polar Lipids, Inc.
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents
This Article
Right arrow Full Text
Right arrow Full Text (PDF, 167K)
Right arrow PPT slides of all figures
Right arrow Alert me when this article is cited
Right arrow Citation Map
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new content in the JEM
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Alonzi, T.
Right arrow Articles by Ciliberto, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Alonzi, T.
Right arrow Articles by Ciliberto, G.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?
© The Rockefeller University Press, 0022-1007/1998/2/461/ $5.00
The Journal of Experimental Medicine, Volume 187, Number 4, February 16, 1998 461-468

Articles

Interleukin 6 Is Required for the Development of Collagen-induced Arthritis

Tonino Alonzi*, Elena Fattori*, Domenico Lazzaro*, Patrizia Costa*, Lesley Probert{ddagger}, George Kollias{ddagger}, Fabrizio De Benedetti§, Valeria Poli*, and Gennaro Ciliberto*

From the * Istituto Ricerche di Biologia Molecolare P. Angeletti, 00040 Pomezia, Rome, Italy; the {ddagger} Department of Molecular Genetics, Hellenic Pasteur Institute, 115 21 Athens, Greece; and the § Clinica Pediatrica, Universita' degli Studi di Pavia, Istituto di Ricovero e Cura a Carattere Scientifico Policlinico San Matteo, 27100 Pavia, Italy

Interleukin-6 (IL-6) is overproduced in the joints of patients with rheumatoid arthritis (RA) and, based on its multiple stimulatory effects on cells of the immune system and on vascular endothelia, osteoclasts, and synovial fibroblasts, is believed to participate in the development and clinical manifestations of this disease. In this study we have analysed the effect of ablating cytokine production in two mouse models of arthritis: collagen-induced arthritis (CIA) in DBA/1J mice and the inflammatory polyarthritis of tumor necrosis factor {alpha} (TNF-{alpha}) transgenic mice. IL-6 was ablated by intercrossing an IL-6 null mutation into both arthritis-susceptible genetic backgrounds and disease development was monitored by measuring clinical, histological, and biochemical parameters. Two opposite responses were observed; while arthritis in TNF-{alpha} transgenic mice was not affected by inactivation of the IL-6 gene, DBA/1J, IL-6–/– mice were completely protected from CIA, accompanied by a reduced antibody response to type II collagen and the absence of inflammatory cells and tissue damage in knee joints. These results are discussed in the light of the present knowledge of cytokine networks in chronic inflammatory disorders and suggest that IL-6 receptor antagonists might be beneficial for the treatment of RA.

We wish to thank Mr. M. Aquilina and Mrs. S. Germoni (Istituto Ricerche di Biologia Molecolare; IRBM) for animal care, H. Bazin for the generous gift of LO-DNP-57 antibody, and Drs. A. Nicosia, M. Sollazzo, and C. Toniatti, and Mrs. J. Clench (IRBM) for critically reading the manuscript.

Address correspondence to Gennaro Ciliberto, IRBM P. Angeletti, Via Pontina Km 30,600, 00040 Pomezia, Rome, Italy. Phone: 39-6-91093205; Fax: 39-6-91093654; E-mail: ciliberto{at}irbm.it

The present address of T. Alonzi and V. Poli is Department of Biochemistry, Wellcome Trust Building, University of Dundee, Dundee DD1 4HN, UK.

1 Abbreviations used in this paper: CII, type II collagen; CIA, collagen-induced arthritis; DIL, DBA/1J, IL-6; DIL-6, DBA/1J mice crossed with IL-6–deficient mice; gp, glycoprotein; RA, rheumatoid arthritis; sIL-6R{alpha}, soluble IL-6 receptor subunit {alpha}; TIL, TNF, IL-6; TIL-6, TNF-{alpha} transgenic mice crossed with IL-6–deficient mice.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?




  Home | Help | Feedback | Subscriptions | Archive | Search
TABLE OF CONTENTS